EarGenie MVP Performance Evaluation - Trial NCT06406088
Access comprehensive clinical trial information for NCT06406088 through Pure Global AI's free database. This phase not specified trial is sponsored by The Bionics Institute of Australia and is currently Not yet recruiting. The study focuses on Hearing Impaired Children. Target enrollment is 50 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
The Bionics Institute of Australia
Timeline & Enrollment
N/A
Jun 15, 2024
Dec 15, 2025
Primary Outcome
Performance of the EarGenie test of sound detection for a range of sound levels in normal-hearing infants.,Performance of the EarGenie test of speech discrimination for a range of speech sound contrasts in normal-hearing infants
Summary
This is a single-group clinical trial to evaluate the performance of the EarGenie minimum
 viable product (MVP) in normal hearing infants. The EarGenie MVP tests for detection and
 discrimination of sounds will be administered, and the sensitivity and specificity of the
 tests will be estimated for a range of sound levels (detection) and speech sound contrasts
 (discrimination).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06406088
Device Trial